Fig. 1
Trial schema for this phase I/II study assessing carfilzomib, bendamustine, and dexamethasone in newly diagnosed myeloma patients.
Fig. 1 | Blood Cancer Journal
Trial schema for this phase I/II study assessing carfilzomib, bendamustine, and dexamethasone in newly diagnosed myeloma patients.
